Skip to content

Editorial

Editorial standards & methodology

How entries on peptideinfo.wiki are researched, written, and labelled, so you can judge the information for yourself.

Sourcing

Each entry is compiled from primary and secondary literature: peer-reviewed journal articles (indexed on PubMed/PMC), regulatory documents (FDA, EMA), and established reference databases. Every entry lists its sources, and we link to the original wherever a public link exists. We aim to cite the original study rather than secondary summaries.

How we represent evidence

We distinguish explicitly between in vitro (cell-culture), animal, and human evidence, and we note the size and quality of studies. Where the evidence is preliminary, mixed, or contested, we say so plainly rather than presenting it as settled. We would rather under-claim than overstate.

Evidence levels

Every peptide carries an evidence-level label (shown as a colour-coded chip in its “In brief” box) that summarises how strong the evidence is and whether it is approved. For approved compounds we also state exactly where they are approved. The labels mean:

Approved medicine
Approved by a major regulator (the FDA and/or the EMA) for one or more specific indications, and used under prescription. We always state where it is approved — approval in one country does not mean approval everywhere.
Approved abroad — not FDA/EMA
Authorised by a national regulator (for example in Russia, Japan, or parts of Asia) but not by the US FDA or the European Medicines Agency. Approval standards vary by country.
Investigational — active human trials
Under active clinical study in humans but not approved by any regulator. Generally available only within clinical trials.
Limited/early human data — not approved
Some small or early-stage human studies exist, but it is not approved and the evidence is preliminary. Usually handled only as a research chemical.
Preclinical — animal/in-vitro only
Evidence comes almost entirely from cell and animal studies, with no established human trials. Not approved for human use.
Mixed / disputed evidence
Human evidence exists but is inconsistent or contested between independent reviews and other sources.

Not medical advice, and not medically reviewed

We are transparent about what this is and is not. Entries are an educational summary of published research. They are not medical advice, not written or individually reviewed by a licensed clinician for your circumstances, and not a recommendation to obtain or use any substance. Many peptides documented here are not approved for human use. Always consult a qualified healthcare professional before making health decisions.

We deliberately do not publish dosing protocols, administration instructions, or sourcing/vendor information for unapproved substances. Where a study used a particular dose, we may report that fact in describing the research, not as guidance.

No commercial conflict

PeptideInfo Wiki does not sell peptides, does not link to vendors, and does not publish affiliate or sponsored content. Nothing on this site is written to promote a product.

Corrections

Science changes and errors happen. Each entry shows when it was last updated. If you find an inaccuracy or have a peer-reviewed source to suggest, we want to fix it — email info@peptideinfo.wiki. See About for more on the project.